Navigation Links
Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Date:5/25/2011

NEW YORK, May 25, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

http://www.reportlinker.com/p0511090/Drug-Delivery-Devices-Market-Outlook-in-Russian-Federation-to-2017---Metered-Dose-Inhaler-Devices-Infusion-Systems-Central-Venous-Catheters-and-Needle-Free-Injections.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Summary

GlobalData's new report, "Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections" provides key market data on the Russian Federation Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories -- Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the four market categories.

- Global corporate-level profiles of key companies operating within the Russian Federation Drug Delivery Devices market.

- Key players covered include GlaxoSmithKline plc, Baxter International Inc., Boehringer Ingelheim GmbH, Medtronic, Inc., CareFusion Corporation, Fresenius Kabi AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Russian Federation Drug Delivery Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 11

2.1 What is This Report About? 11

3 Drug Delivery Devices In Russian Federation 12

3.1 Drug Delivery Devices, Market Segmentation 12

3.2 Drug Delivery Devices, Russian Federation, Overall Revenue ($m), 2003-2017 13

3.3 Drug Delivery Devices Market, Russian Federation, Revenue Mix ($m), 2010 15

3.4 Drug Delivery Devices Market, Russian Federation, Category Contribution (%), 2010 16

3.5 Drug Delivery Devices, Russian Federation, Category Volume (Units), 2003-2017 22

3.6 Drug Delivery Devices, Russian Federation, Company Share (2009-2010) 27

4 Central Venous Catheters In Russian Federation 29

4.1 Central Venous Cath Central Venous Catheters, Market Segmentation 29

4.2 Central Venous Catheters Market, Russian Federation, Revenue Mix ($m), 2010 30

4.3 Central Venous Catheters Market, Russian Federation, Segment Contribution (%), 2010 31

4.4 Central Venous Catheters Overall Revenue (2003-2017) 32

4.5 Central Venous Catheters Overall Volume (2003-2017) 36

4.6 Central Venous Catheters Average Price (2003-2017) 40

4.7 Central Venous Catheters Distribution Share (2009-2010) 41

4.8 Central Venous Catheters, Russian Federation, Company Share (2009-2010) 42

5 Infusion Systems In Russian Federation 44

5.1 Infusion Systems, Market Segmentation 44

5.2 Infusion Systems Market, Russian Federation, Revenue Mix ($m), 2010 45

5.3 Infusion Systems Market, Russian Federation, Segment Contribution (%), 2010 46

5.4 Infusion Systems Overall Revenue (2003-2017) 47

5.4.1 Syringe Pumps Revenue (2003-2017) 51

5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017) 55

5.5 Infusion Systems Overall Volume (2003-2017) 59

5.5.1 Syringe Pumps Volume (2003-2017) 63

5.5.2 Ambulatory Infusion Pumps Volume (2003-2017) 67

5.6 Infusion Systems Average Price (2003-2017) 71

5.7 Infusion Systems Distribution Share (2009-2010) 72

5.8 Infusion Systems, Russian Federation, Company Share (2009-2010) 73

6 Metered Dose Inhaler Devices In Russian Federation 75

6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 75

6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 77

6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 79

6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 80

6.5 Metered Dose Inhaler Devices, Russian Federation, Company Share (2009-2010) 81

7 Needle Free Injections In Russian Federation 83

7.1 Needle Free Injections Overall Revenue (2003-2017) 83

7.2 Needle Free Injections Overall Volume (2003-2017) 85

7.3 Needle Free Injections Average Price (2003-2017) 87

7.4 Needle Free Injections Distribution Share (2009-2010) 88

7.5 Needle Free Injections, Russian Federation, Company Share (2009-2010) 89

8 Overview of Key Companies in Russian Federation Drug Delivery Devices Market 90

8.1 GlaxoSmithKline plc 90

8.1.1 Company Overview 90

8.1.2 Share in the Russian Federation Drug Delivery Devices Market 90

8.2 Baxter International Inc. 91

8.2.1 Company Overview 91

8.2.2 Share in the Russian Federation Drug Delivery Devices Market 91

8.3 Boehringer Ingelheim GmbH 92

8.3.1 Company Overview 92

8.3.2 Share in the Russian Federation Drug Delivery Devices Market 92

8.4 Medtronic, Inc. 93

8.4.1 Company Overview 93

8.4.2 Share in the Russian Federation Drug Delivery Devices Market 93

8.5 CareFusion Corporation 94

8.5.1 Company Overview 94

8.5.2 Share in the Russian Federation Drug Delivery Devices Market 94

8.6 Fresenius Kabi AG 95

8.6.1 Company Overview 95

8.6.2 Share in the Russian Federation Drug Delivery Devices Market 95

8.7 AstraZeneca PLC 96

8.7.1 Company Overview 96

8.8 Hospira, Inc. 96

8.8.1 Company Overview 96

8.9 B. Braun Melsungen AG 96

8.9.1 Company Overview 96

8.10 Terumo Corporation 97

8.10.1 Company Overview 97

8.11 Smiths Medical 97

8.11.1 Company Overview 97

8.12 Codman & Shurtleff, Inc. 97

8.12.1 Company Overview 97

8.13 Teleflex Incorporated 98

8.13.1 Company Overview 98

8.14 Consort Medical plc 98

8.14.1 Company Overview 98

8.15 INJEX - Equidyne Systems 98

8.15.1 Company Overview 98

8.16 Antares Pharma, Inc. 99

8.16.1 Company Overview 99

8.17 Bioject Medical Technologies Inc. 99

8.17.1 Company Overview 99

8.18 Edwards Lifesciences Corporation 100

8.18.1 Company Overview 100

8.19 Becton, Dickinson and Company 100

8.19.1 Company Overview 100

9 Drug Delivery Devices Market Pipeline Products 101

10 Appendix 106

10.1 Definitions of Markets Covered in the Report 107

10.1.1 Drug Delivery Devices 107

10.2 Research Methodology 110

10.3 Secondary Research 110

10.4 Primary Research 111

10.5 Models 111

10.6 Forecasts 112

10.7 Expert Panels 112

10.8 GlobalData Consulting 112

10.9 Currency Conversion 112

10.10 Contact Us 113

10.11 Disclaimer 113

1.1 List of Tables

Table 1: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), 2003-2017 14

Table 2: Drug Delivery Devices Market, Russian Federation, Category Contribution (%), 2010 16

Table 3: Drug Delivery Devices, Russian Federation Cross-Category Analysis, 2003-2017 17

Table 4: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), Historic, 2003-2010 19

Table 5: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), Forecast, 2010-2017 21

Table 6: Drug Delivery Devices, Russian Federation, Category Volume (Units), 2003-2017 22

Table 7: Drug Delivery Devices, Russian Federation, Category Volume (Units), Historic, 2003-2010 24

Table 8: Drug Delivery Devices, Russian Federation, Category Volume (Units), Forecast, 2010-2017 26

Table 9: Drug Delivery Devices, Russian Federation, Company Share by Revenue ($m), 2009-2010 28

Table 10: Central Venous Catheters Market, Russian Federation, Segment Contribution (%), 2010 31

Table 11: Central Venous Catheters, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 33

Table 12: Central Venous Catheters, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 35

Table 13: Central Venous Catheters, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 37

Table 14: Central Venous Catheters, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 39

Table 15: Central Venous Catheters, Russian Federation, Average Price ($), Historic, 2003-2010 40

Table 16: Central Venous Catheters, Russian Federation, Average Price ($), Forecast, 2010-2017 40

Table 17: Central Venous Catheters, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 41

Table 18: Central Venous Catheters, Russian Federation, Company Share by Revenue ($m), 2009-2010 43

Table 19: Infusion Systems Market, Russian Federation, Segment Contribution (%), 2010 46

Table 20: Infusion Systems, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 48

Table 21: Infusion Systems, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 50

Table 22: Syringe Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Historic, 2003-2010 52

Table 23: Syringe Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54

Table 24: Ambulatory Infusion Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56

Table 25: Ambulatory Infusion Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58

Table 26: Infusion Systems, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 60

Table 27: Infusion Systems, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 62

Table 28: Syringe Pumps, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 64

Table 29: Syringe Pumps, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 66

Table 30: Ambulatory Infusion Pumps, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 68

Table 31: Ambulatory Infusion Pumps, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 70

Table 32: Infusion Systems, Russian Federation, Average Price ($), Historic, 2003-2010 71

Table 33: Infusion Systems, Russian Federation, Average Price ($), Forecast, 2010-2017 71

Table 34: Infusion Systems, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 72

Table 35: Infusion Systems, Russian Federation, Company Share by Revenue ($m), 2009-2010 74

Table 36: Metered Dose Inhaler Devices, Russian Federation, Revenue ($m), Historic, 2003-2010 75

Table 37: Metered Dose Inhaler Devices, Russian Federation, Revenue ($m), Forecast, 2010-2017 76

Table 38: Metered Dose Inhaler Devices, Russian Federation, Volume (Units), Historic, 2003-2010 77

Table 39: Metered Dose Inhaler Devices, Russian Federation, Volume (Units), Forecast, 2010-2017 78

Table 40: Metered Dose Inhaler Devices, Russian Federation, Average Price ($), Historic, 2003-2010 79

Table 41: Metered Dose Inhaler Devices, Russian Federation, Average Price ($), Forecast, 2010-2017 79

Table 42: Metered Dose Inhaler Devices, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 80

Table 43: Metered Dose Inhaler Devices, Russian Federation, Company Share by Revenue ($m), 2009-2010 82

Table 44: Needle Free Injections, Russian Federation, Revenue ($m), Historic, 2003-2010 83

Table 45: Needle Free Injections, Russian Federation, Revenue ($m), Forecast, 2010-2017 84

Table 46: Needle Free Injections, Russian Federation, Volume (Units), Historic, 2003-2010 85

Table 47: Needle Free Injections, Russian Federation, Volume (Units), Forecast, 2010-2017 86

Table 48: Needle Free Injections, Russian Federation, Average Price ($), Historic, 2003-2010 87

Table 49: Needle Free Injections, Russian Federation, Average Price ($), Forecast, 2010-2017 87

Table 50: Needle Free Injections, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 88

Table 51: Needle Free Injections, Russian Federation, Company Share by Revenue ($m), 2009-2010 89

Table 52: Drug Delivery Devices Market Pipeline Products 101

Table 53: USD to Local Currency, Russian Federation, Average Actual Rate 2003-2010 112

1.2 List of Figures

Figure 1: Drug Delivery Devices, Market Segmentation 12

Figure 2: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), 2003-2017 13

Figure 3: Drug Delivery Devices Market, Russian Federation, Revenue Mix ($m), 2010 15

Figure 4: Drug Delivery Devices Market, Russian Federation, Category Contribution (%), 2010 16

Figure 5: Drug Delivery Devices, Russian Federation, Cross-Category Analysis, 2003-2017 17

Figure 6: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), Historic, 2003-2010 18

Figure 7: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), Forecast, 2010-2017 20

Figure 8: Drug Delivery Devices, Russian Federation, Category Volume (Units), 2003-2017 22

Figure 9: Drug Delivery Devices, Russian Federation, Category Volume (Units), Historic, 2003-2010 23

Figure 10: Drug Delivery Devices, Russian Federation, Category Volume (Units), Forecast, 2010-2017 25

Figure 11: Drug Delivery Devices, Russian Federation, Company Share (%), 2010 27

Figure 12: Central Venous Catheters, Market Segmentation 29

Figure 13: Central Venous Catheters Market, Russian Federation, Revenue Mix ($m), 2010 30

Figure 14: Central Venous Catheters Market, Russian Federation, Segment Contribution (%), 2010 31

Figure 15: Central Venous Catheters, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 32

Figure 16: Central Venous Catheters, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 34

Figure 17: Central Venous Catheters, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 36

Figure 18: Central Venous Catheters, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 38

Figure 19: Central Venous Catheters, Russian Federation, Company Share (%), 2010 42

Figure 20: Infusion Systems, Market Segmentation 44

Figure 21: Infusion Systems Market, Russian Federation, Revenue Mix ($m), 2010 45

Figure 22: Infusion Systems Market, Russian Federation, Segment Contribution (%), 2010 46

Figure 23: Infusion Systems, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 47

Figure 24: Infusion Systems, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 49

Figure 25: Syringe Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Historic, 2003-2010 51

Figure 26: Syringe Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 53

Figure 27: Ambulatory Infusion Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55

Figure 28: Ambulatory Infusion Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57

Figure 29: Infusion Systems, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 59

Figure 30: Infusion Systems, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 61

Figure 31: Syringe Pumps, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 63

Figure 32: Syringe Pumps, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65

Figure 33: Ambulatory Infusion Pumps, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 67

Figure 34: Ambulatory Infusion Pumps, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69

Figure 35: Infusion Systems, Russian Federation, Company Share (%), 2010 73

Figure 36: Metered Dose Inhaler Devices, Russian Federation, Revenue ($m), Historic, 2003-2010 75

Figure 37: Metered Dose Inhaler Devices, Russian Federation, Revenue ($m), Forecast, 2010-2017 76

Figure 38: Metered Dose Inhaler Devices, Russian Federation, Volume (Units), Historic, 2003-2010 77

Figure 39: Metered Dose Inhaler Devices, Russian Federation, Volume (Units), Forecast, 2010-2017 78

Figure 40: Metered Dose Inhaler Devices, Russian Federation, Company Share (%), 2010 81

Figure 41: Needle Free Injections, Russian Federation, Revenue ($m), Historic, 2003-2010 83

Figure 42: Needle Free Injections, Russian Federation, Revenue ($m), Forecast, 2010-2017 84

Figure 43: Needle Free Injections, Russian Federation, Volume (Units), Historic, 2003-2010 85

Figure 44: Needle Free Injections, Russian Federation, Volume (Units), Forecast, 2010-2017 86

Figure 45: Needle Free Injections, Russian Federation, Company Share (%), 2010 89

Figure 46: GlaxoSmithKline plc, Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 90

Figure 47: Baxter International Inc., Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 91

Figure 48: Boehringer Ingelheim GmbH, Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 92

Figure 49: Medtronic, Inc., Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 93

Figure 50: CareFusion Corporation, Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 94

Figure 51: Fresenius Kabi AG, Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 95

Companies Mentioned GlaxoSmithKline plc

Baxter International Inc.

Boehringer Ingelheim GmbH

Medtronic, Inc.

CareFusion Corporation

Fresenius Kabi AG

AstraZeneca PLC

Hospira, Inc.

B. Braun Melsungen AG

Terumo Corporation

Smiths Medical

Codman & Shurtleff, Inc.

Teleflex Incorporated

Consort Medical plc

INJEX - Equidyne Systems

Antares Pharma, Inc.

Bioject Medical Technologies Inc.

Edwards Lifesciences Corporation

Becton, Dickinson and Company

To order this report:

Drug Delivery Technology Industry: Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Drug Delivery Technology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
Breaking Medicine News(10 mins):